Keywords: داروهای ضد انعقاد خوراکی جدید; direct oral anticoagulants; DOAC; novel oral anticoagulants; NOAC; dentoalveolar surgery;
مقالات ISI داروهای ضد انعقاد خوراکی جدید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: داروهای ضد انعقاد خوراکی جدید; Anticoagulant reversal; Novel oral anticoagulants; Warfarin; Heparin; Prothrombin complex concentrate; Idarucizumab;
Keywords: داروهای ضد انعقاد خوراکی جدید; Novel oral anticoagulants; Vitamin K antagonists; Atrial fibrillation ablation; Anticoagulation; Thromboembolism;
Keywords: داروهای ضد انعقاد خوراکی جدید; Novel oral anticoagulants; Dabigatran; Rivaroxaban; Apixaban; New oral anticoagulants use assessment;
Keywords: داروهای ضد انعقاد خوراکی جدید; ACT; activated clotting time; AF; atrial fibrillation; CHA2DS2-VASc; score for prediction of estimated risk of stroke in patients with non-valvular atrial fibrillation; EP; electrophysiologic; HAS-BLED; score that estimates risk of major bleeding for pati
Keywords: داروهای ضد انعقاد خوراکی جدید; Anticoagulation; Novel oral anticoagulants; Regional anesthesia; Neuraxial anesthesia; Perioperative management; ASRA guidelines;
Keywords: داروهای ضد انعقاد خوراکی جدید; Novel oral anticoagulants; Reversal agents; Antidotes; Emergency surgery; Trauma;
Keywords: داروهای ضد انعقاد خوراکی جدید; Anticoagulation; Novel oral anticoagulants; Rivaroxaban; Apixaban; Edoxaban; Dabigatran
Keywords: داروهای ضد انعقاد خوراکی جدید; Cryoballoon ablation; Atrial fibrillation; Novel oral anticoagulants;
Keywords: داروهای ضد انعقاد خوراکی جدید; Network meta-analysis; Novel oral anticoagulants; Atrial fibrillation
Keywords: داروهای ضد انعقاد خوراکی جدید; Novel oral anticoagulants; Apixaban; Dabigatran; Edoxaban; Rivaroxaban; Cost-effectiveness; Atrial fibrillationNovos anticoagulantes orais; Apixabano; Dabigatrano; Edoxabano; Rivaroxabano; Custo-efetividade; Fibrilhação auricular
Keywords: داروهای ضد انعقاد خوراکی جدید; Anticoagulation; Novel oral anticoagulants; Atrial fibrillation; Factor IIa inhibitors; Factor Xa inhibitors; Stroke;
Keywords: داروهای ضد انعقاد خوراکی جدید; Postoperative atrial fibrillation; Anticoagulation; Warfarin; Novel oral anticoagulants;
Keywords: داروهای ضد انعقاد خوراکی جدید; Atrial fibrillation ablation; Anticoagulation; Intracardiac echocardiography; Reversal agents; Novel oral anticoagulants; Warfarin;
Keywords: داروهای ضد انعقاد خوراکی جدید; Antiplatelet; Anticoagulation; Bleeding; Thrombosis; Novel oral anticoagulants
Keywords: داروهای ضد انعقاد خوراکی جدید; Novel oral anticoagulants; Venous thromboembolism; Bleeding; Sex-related differences;
Keywords: داروهای ضد انعقاد خوراکی جدید; Novel oral anticoagulants; Atrial fibrillation; Warfarin; Dabigatran; RivaroxabanAF, atrial fibrillation; CHADS2, cardiac failure, hypertension, age, diabetes, stroke (doubled); CHA2DS2-VASc, congestive heart failure, hypertension, age ≥75 years (doubled)
Elective Cardioversion in the Era of Novel Oral Anticoagulants - Does a Nurse Administered Verbal Questionnaire for Compliance Negate the Need for Routine Transoesophageal Echocardiography?
Keywords: داروهای ضد انعقاد خوراکی جدید; EDCCV; External direct current cardioversion; NOAC; Novel oral anticoagulant; TOE; Transoesophageal echocardiogram; SSE; Stroke or systemic embolism; EPCNC; Electrophysiology clinical nurse consultant; Compliance; External cardioversion; Atrial fibrillati
Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation
Keywords: داروهای ضد انعقاد خوراکی جدید; Atrial fibrillation; Novel oral anticoagulants; Warfarin; Direct current cardioversion procedures;
Stroke After Transcatheter Aortic Valve Replacement: Incidence, Definitions, Etiologies and Management Options
Keywords: داروهای ضد انعقاد خوراکی جدید; transcatheter aortic valve replacement; stroke; transient ischemic attack; cognitive function; mortality; cerebral embolism; heparin; bivalirudin; platelet blockade; novel oral anticoagulants; modified Rankin scale; infarction; hemorrhage; diffusion weigh
An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation
Keywords: داروهای ضد انعقاد خوراکی جدید; Atrial fibrillation; Catheter ablation; Novel oral anticoagulants; Vitamin K antagonists; Stroke; Major bleeding;
Comparison of Anticoagulant Therapy for Atrial Fibrillation - Novel Oral Anticoagulants Versus Vitamin K Antagonists
Keywords: داروهای ضد انعقاد خوراکی جدید; ACC; American College of Cardiology; ACS; Acute Coronary Syndrome; ACT; Activated Clotting Time; AF; Atrial Fibrillation; AHA; American Heart Association; aPCC; Activated Prothrombin Complex Concentrate; aPTT; Activated Partial Thromboplastin Time; CAD; C
ReviewAdvances in oral anticoagulation therapy - What's in the pipeline?
Keywords: داروهای ضد انعقاد خوراکی جدید; Activated factor X inhibitor; Factor Xa; Anticoagulation therapy; Venous thromboembolism; Novel oral anticoagulants;
CYP2C9 and VKORC1 in therapeutic dosing and safety of acenocoumarol treatment: implication for clinical practice in Hungary
Keywords: داروهای ضد انعقاد خوراکی جدید; AC; acenocoumarol; VKA; vitamin K antagonist; NOACs; novel oral anticoagulants; OEP; Hungarian acronym, National Health Insurance Fund of Hungary; INR; International Normalized Ratio; CYP2C9; Cytochrome P450 2C9; VKORC1; Vitamin K Epoxide Reductase Comple
Intracerebral Hemorrhagic Expansion Occurs in Patients Using Non-Vitamin K Antagonist Oral Anticoagulants Comparable with Patients Using Warfarin
Keywords: داروهای ضد انعقاد خوراکی جدید; Critical care; hematoma expansion; intracerebral hemorrhage; novel oral anticoagulants; stroke;
Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study
Keywords: داروهای ضد انعقاد خوراکی جدید; Direct oral anticoagulants; Novel oral anticoagulants; Cancer; Vitamin-K inhibitors; Low-molecular-weight-heparin; Venous thrombo-embolism; Meta-analysis;
Reversal Agents for the New Generation of Oral Anticoagulants: Implications for the Perioperative Physician
Keywords: داروهای ضد انعقاد خوراکی جدید; novel oral anticoagulants; dabigatran; rivaroxaban; edoxaban; apixaban; direct thrombin inhibitor; factor Xa; atrial fibrillation; activated charcoal; prothrombin complex concentrates; vitamin K antagonists; warfarin; recombinant factor VIIa; idarucizumab
Guía de práctica clínica para la prevención, diagnóstico y tratamiento de la enfermedad tromboembólica venosa en el deporte
Keywords: داروهای ضد انعقاد خوراکی جدید; Trombosis venosa profunda; Enfermedad tromboembólica; Heparina; Nuevos anticoagulantes oralesDeep vein thrombosis; Venous thromboembolism; Heparin; Novel oral anticoagulants
Novel oral anticoagulants in non-valvular atrial fibrillation
Keywords: داروهای ضد انعقاد خوراکی جدید; atrial fibrillation; stroke; stroke prevention; stroke risk assessment; bleeding risk assessment; oral anticoagulant therapy; vitamin K antagonists; warfarin; novel oral anticoagulants; dabigatran; rivaroxaban; apixaban; net clinical benefit